LINC00702

Across TCGA pan-cancer cohorts, LINC00702 RNA differs between tumor and matched normal tissue in 15 of 18 cancer types tested, making tumor–normal expression one of LINC00702’s most consistent transcriptional readouts.

The strongest signal is observed in colon adenocarcinoma (COAD), where LINC00702 RNA is repressed in tumor relative to normal tissue. In most cancer types LINC00702 is over-expressed in tumor, although a few such as COAD and LUAD show the opposite, repressed pattern.

COAD, LUAD, and BLCA are the cancer types where LINC00702 tumor–normal differential expression is most reproducible.

RNA tumor vs normal associations by lineage

Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in LINC00702 RNA (log₂); positive values indicate higher expression in tumor. p-values are from the differential-expression test.

Lineage	Gender	Stage	Fold-change	p	Sampling consensus
COAD	Female	II,III,IV	−0.653	<.001	10	view →
LUAD	Female	III,IV	−1.268	<.001	9	view →
BLCA	Male	III,IV	−2.937	.002	8	view →
LUSC	All	III,IV	−1.584	<.001	8	view →
THCA	All	II,III,IV	−0.486	<.001	8	view →
LIHC	Male	All	+0.220	<.001	8	view →
UCEC	All	All	−1.794	<.001	6	view →
BRCA	All	All	−0.580	<.001	6	view →
KIRC	All	All	+0.385	<.001	4	view →
KICH	All	All	−0.271	.007	4	view →
STAD	All	All	−0.725	.008	3	view →
READ	Female	All	−1.312	.002	2	view →

Pink = over-expressed in tumor, green = repressed in tumor. Showing the 12 strongest of 15 lineages.

LINC00702–COAD

Open the COAD breakdown →